User profiles for P. Steiropoulos

Paschalis Steiropoulos

Medical School, Democritus University of Thrace
Verified email at med.duth.gr
Cited by 8138

[HTML][HTML] Impact of air pollution on asthma outcomes

…, HJ Chong-Neto, S Novakova, P Steiropoulos… - International journal of …, 2020 - mdpi.com
Asthma is a chronic respiratory disease characterized by variable airflow obstruction, bronchial
hyperresponsiveness, and airway inflammation. Evidence suggests that air pollution has …

[HTML][HTML] E-cigarette use among adolescents: an overview of the literature and future perspectives

EP Perikleous, P Steiropoulos, E Paraskakis… - Frontiers in public …, 2018 - frontiersin.org
Background Electronic cigarettes (e-cigarettes) are rapidly emerging into a new trend
among adolescents, signaling a new époque, that of vapers. E-cigarettes are battery-powered …

Lung cancer in patients with idiopathic pulmonary fibrosis

…, V Tzilas, R Tringidou, P Steiropoulos… - Pulmonary …, 2017 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease of unknown etiology. With
a gradually increasing worldwide prevalence and a mortality rate exceeding that of many …

[HTML][HTML] Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of …

…, F Sitas, EE Spurlock, P Steiropoulos… - The Lancet …, 2021 - thelancet.com
Background Prevention, control, and treatment of respiratory tract cancers are important steps
towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)—a one-…

Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis

…, E Spanoudakis, P Steiropoulos… - American journal of …, 2009 - atsjournals.org
… In line with the previous data, suppression of TNF-α production was from two- to fourfold
lower in patients with IPF in comparison with HVs (P = 0.005 in PB) and patients without IPF (P = …

Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome

P Steiropoulos, V Tsara, E Nena, C Fitili… - Chest, 2007 - Elsevier
… (p = 0.03), homocysteine (p = 0.005), total cholesterol (p = 0.021), total cholesterol/HDL-C
ratio (p = 0.018), and ApoB/ApoA-I ratio (p … a decrease in homocysteine levels (p = 0.021) only, …

Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome

P Steiropoulos, I Kotsianidis, E Nena, V Tsara… - Sleep, 2009 - academic.oup.com
… the absolute count of total lymphocytes (P = 0.003), and of CD4+ cells (P = 0.001), and a
decrease in TNF-α levels (P = 0.001) and uric acid levels (P < 0.001) was observed after CPAP …

[HTML][HTML] Sleep quality and mental health of medical students in Greece during the COVID-19 pandemic

…, A Rokou, A Arvaniti, E Nena, P Steiropoulos - Frontiers in public …, 2021 - frontiersin.org
… Statistical significance was set at p < 0.05 level. … the 6th year reported significantly shorter
sleep duration (p = 0.003). … of the participants, regardless of gender (p = 0.579), reported being …

The diagnostic method has a strong influence on classification of obstructive sleep apnea

…, T Saaresranta, R Schulz, P Steiropoulos… - Journal of sleep …, 2015 - Wiley Online Library
… Age and BMI distributions were similar among patients investigated using either method,
but the proportion of males was higher in the PSG group (P < 0.0001). There was also a high …

Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity?

…, N Papanas, P Steiropoulos, P Zikidou, P Zarogoulidis… - Platelets, 2012 - Taylor & Francis
Aim of the study: To evaluate Mean Platelet Volume (MPV) and Platelet Distribution Width (PDW)
in non-diabetic subjects, according to obstructive sleep apnoea syndrome (OSAS) …